In Stock
Ulinastatin Injection IP
Ulinastatin Injection IP is a protease inhibitor used in selected clinical conditions to help control excessive inflammatory responses and protect tissues from inflammation-related damage.
Product Details
Ulinastatin Injection IP contains ulinastatin, a naturally occurring urinary trypsin inhibitor with anti-inflammatory and protease-inhibitory properties. It is used in selected clinical settings, particularly where excessive protease activity and systemic inflammation may contribute to tissue injury. Its use should be determined by a qualified healthcare professional based on the patient's condition.
Key Benefits
- Helps reduce excessive inflammatory responses
- Inhibits the activity of certain proteolytic enzymes
- May support tissue protection during severe inflammatory conditions
- Used as supportive therapy in selected critical care situations
- Helps regulate inflammatory processes under medical supervision
How It Works
Ulinastatin inhibits several proteolytic enzymes, including trypsin and other enzymes involved in inflammatory processes. By reducing excessive protease activity, it may help limit tissue damage and modulate inflammatory responses in appropriate clinical conditions.
Common Side Effects
- Nausea
- Vomiting
- Diarrhea
- Headache
- Dizziness
- Injection-site discomfort
- Skin rash or hypersensitivity reactions
Important Information
Ulinastatin Injection IP should be administered by a qualified healthcare professional, generally in a hospital or clinical setting when medically indicated. The dose and duration depend on the patient's condition and treatment response. Inform the healthcare professional about previous drug allergies and existing medical conditions. Seek immediate medical attention if breathing difficulty, facial swelling, severe rash, or other signs of a serious allergic reaction occur.
